Tumor-targeted HPMA copolymer-(RGDfK)-(CHX-A″-DTPA) conjugates show increased kidney accumulation
- 1 December 2008
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 132 (3) , 193-199
- https://doi.org/10.1016/j.jconrel.2008.07.014
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Osteotropic Peptide That Differentiates Functional Domains of the SkeletonBioconjugate Chemistry, 2007
- Polymeric conjugates of mono- and bi-cyclic αVβ3 binding peptides for tumor targetingJournal of Controlled Release, 2006
- Pharmacokinetic and Biodistribution Studies of a Bone-Targeting Drug Delivery System Based onN-(2-Hydroxypropyl)methacrylamide CopolymersMolecular Pharmaceutics, 2006
- Polymer-peptide conjugates for angiogenesis targeted tumor radiotherapyNuclear Medicine and Biology, 2006
- Effect of physicochemical modification on the biodistribution and tumor accumulation of HPMA copolymersJournal of Controlled Release, 2005
- Tumour vascular targetingNature Reviews Cancer, 2005
- Targeting tumor angiogenic vasculature using polymer–RGD conjugatesJournal of Controlled Release, 2005
- The targeting of anionized polyvinylpyrrolidone to the renal systemBiomaterials, 2003
- THERAPEUTIC EFFECT OF ARGININE–GLYCINE–ASPARTIC ACID PEPTIDES IN ACUTE RENAL INJURYClinical and Experimental Pharmacology and Physiology, 1998
- Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrierEuropean Journal Of Cancer, 1995